← Leaderboards
Jonathan S. Weissman
University Of California San Francisco
$11,867,986
Attributed
$31,432,101
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,432,101 · 17
By mechanism
U01$13,359,295 · 4
RM1$9,899,998 · 1
R01$5,490,442 · 7
P01$2,146,099 · 3
R21$536,250 · 1
P41$17 · 1
Top collaborators
- Michael T Mcmanus11 shared
- Wendell A Lim8 shared
- Lei Stanley Qi8 shared
- Sourav Bandyopadhyay6 shared
- Trever G Bivona6 shared
- Frank Patrick Mccormick5 shared
- Brittany S. Adamson4 shared
- Martin Joseph Ankrah Aryee4 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Stanley B Prusiner$54,781,835
- Surachai Supattapone$18,121,125
- Cynthia J. Kenyon$14,520,817
- Michelle L Hermiston$3,634,874
- Giuseppe Legname$1,478,079
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProteinsGeneticCellsGenesComplexVariantMutationTechnologyPathway InteractionsMolecularTissuesLibrariesProgramsGenomeMalignant NeoplasmsInterestResponseEpigenetic ProcessNovel StrategiesClustered Regularly Interspaced Short Palindromic RepeatsCodeGenomicsGrowth
Grant awards (44)
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,450,000
RM1 · FY2025 · HG · contact PI
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,449,998
RM1 · FY2024 · HG · contact PI
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,500,000
RM1 · FY2023 · HG · contact PI
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease$2,500,000
RM1 · FY2022 · HG · contact PI
Bay Area Cancer Target Discovery and Development$969,145
U01 · FY2022 · CA
The Cancer Target Discovery and Development Network at UCSF$1,026,728
U01 · FY2021 · CA
Defining Molecular Signatures Underlying Lysosomal Dysfunction in Alzheimerâs Disease$536,250
R21 · FY2021 · AG · contact PI
Novel Components of the mTORC1 and mTORC2 Pathways$487,500
R01 · FY2021 · AI · contact PI
Cell Growth Signaling in Cancer Development$463,125
R01 · FY2021 · CA · contact PI
Regulation of the mTOR Pathway by Nutrients$416,813
R01 · FY2021 · CA · contact PI
Exploiting mitochondrial heteroplasmy for cancer chemotherapy$390,000
R01 · FY2021 · CA · contact PI
The Cancer Target Discovery and Development Network at UCSF$1,029,182
U01 · FY2020 · CA
The Cancer Target Discovery and Development Network at UCSF$1,000,618
U01 · FY2019 · CA
The Cancer Target Discovery and Development Network at UCSF$1,158,875
U01 · FY2018 · CA
The Cancer Target Discovery and Development Network at UCSF$1,034,211
U01 · FY2017 · CA
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$513,541
R01 · FY2017 · DA · contact PI
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$97,313
R01 · FY2017 · DA · contact PI
Bay Area Cancer Target Discovery and Development Network$771,465
U01 · FY2016 · CA
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$513,541
R01 · FY2016 · DA · contact PI
Human Gene Knockdowns that May Extend Lifespan$316,725
R01 · FY2016 · AG · contact PI
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$149,993
R01 · FY2016 · DA · contact PI
Bay Area Cancer Target Discovery and Development Network$811,078
U01 · FY2015 · CA
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$513,541
R01 · FY2015 · DA · contact PI
Human Gene Knockdowns that May Extend Lifespan$307,223
R01 · FY2015 · AG · contact PI
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$119,828
R01 · FY2015 · DA · contact PI
Structural Basis of Protein Homeostasis$1,079,168
U01 · FY2014 · GM
Bay Area Cancer Target Discovery and Development Network$787,464
U01 · FY2014 · CA
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$512,056
R01 · FY2014 · DA · contact PI
Structural Basis of Protein Homeostasis$1,039,242
U01 · FY2013 · GM
Bay Area Cancer Target Discovery and Development Network$769,535
U01 · FY2013 · CA
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming$508,951
R01 · FY2013 · DA · contact PI
Structural Basis of Protein Homeostasis$1,087,760
U01 · FY2012 · GM
Bay Area Cancer Target Discovery and Development Network$794,824
U01 · FY2012 · CA
Molecular Analysis of Yeast Prions$239,353
P01 · FY2011 · AG · contact PI
MASS SPECTROMETRY OF PROTEINS DERIVED FROM SHORT OPEN READING FRAME$17
P41 · FY2011 · RR · contact PI
MOLECULAR ANALYSIS OF YEAST PRIONS$243,426
P01 · FY2009 · AG · contact PI
MOLECULAR ANALYSIS OF YEAST PRIONS$240,986
P01 · FY2008 · AG · contact PI
MOLECULAR ANALYSIS OF YEAST PRIONS$243,474
P01 · FY2007 · AG · contact PI
MOLECULAR ANALYSIS OF YEAST PRIONS$161,498
P01 · FY2006 · AG · contact PI
MOLECULAR ANALYSIS OF YEAST PRIONS$159,899
P01 · FY2005 · AG
Biochemical and genetic analysis of prion formation$285,821
P01 · FY2002 · AG
Biochemical and genetic analysis of prion formation$285,821
P01 · FY2001 · AG
Biochemical and genetic analysis of prion formation$285,821
P01 · FY2000 · AG
MECHANISM OF CHAPERONE MEDIATED PROTEIN FOLDING$180,292
R01 · FY2000 · GM